A next generation prefilled insulin pen launched
Novo Nordisk, world's one of the leading healthcare companies in diabetes care has launched a next generation FlexPen®, a pre-filled insulin delivery device, which has a significantly lower injection force, says a press release.
The reduced injection force leads to lesser pain, more comfort and ease of use for the person with diabetes, encouraging compliance with the regimen. Mevlin Oscar D'souza, Managing Director, ROI said that next generation FlexPen® has been available in some countries from late 2008 and now it is being launched in Bangladesh.
The Next Generation FlexPen® has been tested among patients to assess if the new features translated into actual patient preference. In total, 95% of patients who tried the next generation of FlexPen® said they would prefer to use it, over the current version of FlexPen®. Eighty-nine percent found it more convenient to use, 98% said it took less effort to inject and 83% felt it was safer to operate than the current version of FlexPen.
A. Rajan Kumar, Managing Director, Novo Nordisk, Bangladesh said that it is a result of more than 25 years of research and development of insulin delivery systems undertaken since Novo Nordisk invented the insulin pen.
For all latest news, follow The Daily Star's Google News channel.
Comments